Results 21 to 30 of about 29,916 (215)

Redo aortic valve replacement vs valve-in-valve trans-catheter aortic valve implantation: a UK propensity-matched analysis

open access: yesMonaldi Archives for Chest Disease, 2023
This study sought to compare the morbidity and mortality of redo aortic valve replacement (redo-AVR) versus valve-in-valve trans-catheter aortic valve implantation (valve-in-valve TAVI) for patients with a failing bioprosthetic valve.
Francesca Gatta   +50 more
doaj   +1 more source

Transapical transcatheter mitral valve implantation with J-valve in patients with degenerated mitral bioprostheses

open access: yesBMC Cardiovascular Disorders, 2023
Background Due to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years, the incidence of valve failure has increased significantly, which is facing the need of reoperation.
Fan He   +5 more
doaj   +1 more source

Optimising percutaneous valve-in-valve TAVI with bioprosthetic valve fracture

open access: yesAnnals, Academy of Medicine, Singapore
Percutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable patients, for high, intermediate and low surgical-risk patients over 65 years old with severe aortic valve stenosis (AS).1,2 Valve-in-valve (ViV)
Paul TL Chiam   +3 more
doaj   +1 more source

India’s first percutaneous tricuspid valve implantation: Valve-in-valve is a treatment option for bioprosthetic valve dysfunction

open access: yesIHJ Cardiovascular Case Reports, 2017
Bioprosthetic valve dysfunction leading to haemodynamically significant consequences is well recognised. Traditional treatment of choice has been conventional re-do surgical valve replacement. However, over the last decade, percutaneous solutions such as
A.B. Gopalamurugan   +2 more
doaj   +1 more source

Repeated valve replacement: approaches and devices (literature review)

open access: yesКардиоваскулярная терапия и профилактика, 2023
Bioprosthetic valve dysfunction represent a serious drawback that limits the wider clinical use of these medical devices for valvular heart disease surgery.
K. Yu. Klyshnikov   +3 more
doaj   +1 more source

Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients

open access: yesFrontiers in Cardiovascular Medicine
BackgroundLong-term mortality risk is seldom re-assessed in contemporary clinical practice following successful transcatheter aortic valve implantation (TAVR).
Thomas Meredith   +25 more
doaj   +1 more source

Transseptal Mitral Valve-in-Valve-in-Valve

open access: yesCASE
[Figure: see text]
Blanaid Canavan   +6 more
openaire   +3 more sources

Valves and Valve Gearing [PDF]

open access: yesProceedings of the Institution of Automobile Engineers, 1909
n ...
openaire   +1 more source

Transcatheter Mitral Valve-in-Valve Implantations Using Inverted J-Valve

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundAs bioprosthetic valves are being widely used, the incidence of structural valve deterioration increases, as well as the need for reoperation. Transcatheter mitral valve-in-valve implantations are being increasingly adopted as an alternative to
Lulu Liu   +3 more
doaj   +1 more source

Hydrogel platforms for 3D cardiac tissue engineering and fibrotic disease modelling

open access: yesFEBS Open Bio, EarlyView.
Hydrogel‐based cardiac tissue models are advancing our understanding of heart health and disease. By incorporating electrical conductivity, aligned structures, and tunable mechanical properties, these platforms better replicate the complex environment of native heart tissue.
Harrison Porritt   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy